Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

Overview of attention for article published in Journal of Hematology & Oncology, December 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 1 news story.

Oncologia ed Ematologia Cellule CAR-T, conferme di lunga sopravvivenza con brexu-cel nella leucemia linfoblastica acuta e nel…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.